"Tumor Cells, Cultured" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Cells grown in vitro from neoplastic tissue. If they can be established as a TUMOR CELL LINE, they can be propagated in cell culture indefinitely.
Concept/Terms
Tumor Cells, Cultured- Tumor Cells, Cultured
- Neoplastic Cells, Cultured
- Cultured Neoplastic Cells
- Cell, Cultured Neoplastic
- Cells, Cultured Neoplastic
- Cultured Neoplastic Cell
- Neoplastic Cell, Cultured
- Cultured Tumor Cells
- Cell, Cultured Tumor
- Cells, Cultured Tumor
- Cultured Tumor Cell
- Tumor Cell, Cultured
Below are MeSH descriptors whose meaning is more general than "Tumor Cells, Cultured".
Below are MeSH descriptors whose meaning is more specific than "Tumor Cells, Cultured".
This graph shows the total number of publications written about "Tumor Cells, Cultured" by people in Harvard Catalyst Profiles by year, and whether "Tumor Cells, Cultured" was a major or minor topic of these publication.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1991 | 1 | 91 | 92 |
| 1992 | 4 | 165 | 169 |
| 1993 | 2 | 200 | 202 |
| 1994 | 4 | 191 | 195 |
| 1995 | 5 | 239 | 244 |
| 1996 | 4 | 230 | 234 |
| 1997 | 1 | 239 | 240 |
| 1998 | 6 | 253 | 259 |
| 1999 | 1 | 252 | 253 |
| 2000 | 6 | 298 | 304 |
| 2001 | 9 | 291 | 300 |
| 2002 | 2 | 304 | 306 |
| 2003 | 5 | 213 | 218 |
| 2004 | 0 | 83 | 83 |
| 2005 | 3 | 62 | 65 |
| 2006 | 0 | 70 | 70 |
| 2007 | 1 | 54 | 55 |
| 2008 | 0 | 50 | 50 |
| 2009 | 0 | 70 | 70 |
| 2010 | 1 | 70 | 71 |
| 2011 | 0 | 52 | 52 |
| 2012 | 1 | 64 | 65 |
| 2013 | 1 | 85 | 86 |
| 2014 | 0 | 67 | 67 |
| 2015 | 0 | 62 | 62 |
| 2016 | 1 | 86 | 87 |
| 2017 | 0 | 93 | 93 |
| 2018 | 0 | 76 | 76 |
| 2019 | 1 | 72 | 73 |
| 2020 | 0 | 47 | 47 |
Below are the most recent publications written about "Tumor Cells, Cultured" by people in Profiles.
-
HIF1A signaling selectively supports proliferation of breast cancer in the brain. Nat Commun. 2020 12 09; 11(1):6311.
-
E74-Like Factor 3 Is a Key Regulator of Epithelial Integrity and Immune Response Genes in Biliary Tract Cancer. Cancer Res. 2021 01 15; 81(2):489-500.
-
PGC1a regulates mitochondrial oxidative phosphorylation involved in cisplatin resistance in ovarian cancer cells via nucleo-mitochondrial transcriptional feedback. Exp Cell Res. 2021 01 01; 398(1):112369.
-
REV1 inhibitor JH-RE-06 enhances tumor cell response to chemotherapy by triggering senescence hallmarks. Proc Natl Acad Sci U S A. 2020 11 17; 117(46):28918-28921.
-
Enhanced Efficacy of Simultaneous PD-1 and PD-L1 Immune Checkpoint Blockade in High-Grade Serous Ovarian Cancer. Cancer Res. 2021 01 01; 81(1):158-173.
-
Single-Cell Transcriptomic Heterogeneity in Invasive Ductal and Lobular Breast Cancer Cells. Cancer Res. 2021 01 15; 81(2):268-281.
-
Novel inhibitors of the histone methyltransferase DOT1L show potent antileukemic activity in patient-derived xenografts. Blood. 2020 10 22; 136(17):1983-1988.
-
Low dose amiodarone reduces tumor growth and angiogenesis. Sci Rep. 2020 10 22; 10(1):18034.
-
Identification of TNO155, an Allosteric SHP2 Inhibitor for the Treatment of Cancer. J Med Chem. 2020 11 25; 63(22):13578-13594.
-
Patient-derived Organoid Pharmacotyping is a Clinically Tractable Strategy for Precision Medicine in Pancreatic Cancer. Ann Surg. 2020 09 01; 272(3):427-435.